InvestorsHub Logo
Followers 8
Posts 328
Boards Moderated 0
Alias Born 01/11/2014

Re: None

Tuesday, 10/28/2014 7:13:15 PM

Tuesday, October 28, 2014 7:13:15 PM

Post# of 34575
I am not a trader of TPIV. I will hold until the end of Phase 2 testing when the stock price will soar over $30 per share with hopefully positive results for both trials. But if Galena had positive Phase 2 trials with an inferior product, how can TapImmune not have even better Phase 2 results?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News